Kamada Ltd. (TLV:KMDA)
2,480.00
+101.00 (4.25%)
Aug 7, 2025, 5:24 PM IDT
Paramount Global Market Cap
Kamada has a market cap or net worth of 1.43 billion as of August 8, 2025. Its market cap has increased by 18.74% in one year.
Market Cap
1.43B
Enterprise Value
1.19B
Revenue
622.70M
Ranking
n/a
PE Ratio
23.73
Stock Price
$2,480.00
Market Cap Chart
Since September 12, 2005, Kamada's market cap has increased from 84.35M to 1.43B, an increase of 1,595.89%. That is a compound annual growth rate of 15.27%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 7, 2025 | 1.43B | 12.54% |
Dec 31, 2024 | 1.27B | -0.69% |
Dec 31, 2023 | 1.28B | 108.12% |
Dec 29, 2022 | 615.02M | -33.18% |
Dec 30, 2021 | 920.36M | -0.46% |
Dec 31, 2020 | 924.59M | -3.70% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 62.13B |
Danel (Adir Yeoshua) | 2.52B |
Bait Bakfar | 1.09B |
SofWave Medical | 989.07M |
BrainsWay | 778.61M |
Novolog (Pharm-Up 1966) | 679.46M |
Ilex Medical | 665.02M |
Bonus BioGroup | 300.16M |